Education
About Us
Working with TipRanks
Follow Us
Chiome Bioscience Inc. (JP:4583)
:4583
RESEARCH TOOLSreports
Total Valuation
Chiome Bioscience Inc. has a market cap or net worth of ¥10.07B. The enterprise value is ¥8.53B.
Market Cap¥10.07B
Enterprise Value¥8.53B
Share Statistics
Chiome Bioscience Inc. has 68,053,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding68,053,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Chiome Bioscience Inc.’s return on equity (ROE) is -0.53 and return on invested capital (ROIC) is -45.82%.
Return on Equity (ROE)-0.53
Return on Assets (ROA)-0.41
Return on Invested Capital (ROIC)-45.82%
Return on Capital Employed (ROCE)-0.52
Revenue Per Employee16.61M
Profits Per Employee-21.72M
Employee Count47
Asset Turnover0.32
Inventory Turnover7.54
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio5.72
Price to Fair Value8.15
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio-1.31
Income Statement
In the last 12 months, Chiome Bioscience Inc. had revenue of 780.81M and earned -1.02B in profits. Earnings per share was -17.54.
Revenue780.81M
Gross Profit432.85M
Operating Income-1.03B
Pretax Income-1.02B
Net Income-1.02B
EBITDA-1.01B
Earnings Per Share (EPS)-17.54
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Chiome Bioscience Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.94
52-Week Price Change14.96%
50-Day Moving Average147.28
200-Day Moving Average163.64
Relative Strength Index (RSI)46.21
Average Volume (3m)1.40M
Important Dates
Chiome Bioscience Inc. upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Chiome Bioscience Inc. as a current ratio of 4.74, with Debt / Equity ratio of 15.98%
Current Ratio4.74
Quick Ratio4.64
Debt to Market Cap0.02
Net Debt to EBITDA1.76
Interest Coverage Ratio-359.81
Taxes
In the past 12 months, Chiome Bioscience Inc. has paid 3.24M in taxes.
Income Tax3.24M
Effective Tax Rate>-0.01
Enterprise Valuation
Chiome Bioscience Inc. EV to EBITDA ratio is -13.69, with an EV/FCF ratio of -13.87.
EV to Sales17.77
EV to EBITDA-13.69
EV to Free Cash Flow-13.87
EV to Operating Cash Flow-13.87
Balance Sheet
Chiome Bioscience Inc. has ¥2.06B in cash and marketable securities with ¥281.50M in debt, giving a net cash position of -¥1.78B billion.
Cash & Marketable Securities¥2.06B
Total Debt¥281.50M
Net Cash-¥1.78B
Net Cash Per Share-¥26.18
Tangible Book Value Per Share¥32.99
Margins
Gross margin is 57.79%, with operating margin of -132.03%, and net profit margin of -130.73%.
Gross Margin57.79%
Operating Margin-132.03%
Pretax Margin-130.32%
Net Profit Margin-130.73%
EBITDA Margin-129.80%
EBIT Margin-132.03%
Analyst Forecast
The average price target for Chiome Bioscience Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast14.41%
EPS Growth Forecast27.42%